Irritable Bowel Syndrome Trial, Recruiting NCT05680766 Sponsor: Universitair Ziekenhuis Brussel Condition: Irritable Bowel Syndrome
Back to Irritable Bowel Syndrome

Irritable Bowel Syndrome Trial, Recruiting

NCT05680766
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People between 18 and 60 years old
  • People who have been diagnosed with Irritable Bowel Syndrome (IBS) according to a standard set of medical guidelines called the ROME IV criteria
  • People whose IBS symptoms are rated as moderate or above, based on a specific IBS symptom scoring tool (a score above 175 on the IBS-Symptom Severity Scale)
  • People who spend a lot of time sitting each day (more than 8 hours per day, based on a specific activity questionnaire)
  • People who do less than 150 minutes of physical activity per week, based on a standard physical activity assessment

Who may not be able to join:

  • People with a heart or lung condition that would make it unsafe to take part in an exercise program (as determined by a specific medical screening questionnaire)
  • People where doctors suspect a bowel or digestive condition other than IBS — though participation may be possible if that other condition has been ruled out (confirm with trial site)
  • People with a known inflammatory bowel disease (such as Crohn's disease or ulcerative colitis)
  • People with a known condition affecting how the bowel moves food through the digestive system
  • People who drink more than 14 units of alcohol per week, or who have issues with other substance use
  • People with an active psychiatric (mental health) condition
  • People with a known condition affecting the whole body's immune system that also affects the digestive system
  • People who have had previous abdominal surgery — except for appendix removal or gallbladder removal, if that surgery was more than 6 months ago
  • People who have ever been diagnosed with any type of cancer, except for a common and very localised form of skin cancer called basocellular carcinoma
  • People currently receiving chemotherapy
  • People who had a stomach or bowel infection (gastroenteritis) in the past 8 weeks
  • People who have changed their diet in the past 8 weeks
  • People taking dietary supplements, unless they have been taking the same dose for more than 8 weeks
  • People who have taken antibiotics, prebiotics, probiotics, postbiotics, or any combination of these in the past 8 weeks
  • People taking certain nerve-acting medications (called neuromodulators), unless they have been on a stable dose of one such medication for more than 12 weeks
  • People who have taken certain bowel-related medications — including antispasmodics, opioids, loperamide, gelatine tannate, or mucoprotectants — in the past 8 weeks

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +32 2 477

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Universitair Ziekenhuis Brussel
Registry
ClinicalTrials.gov
Start date
16 October 2023
Est. completion
2 January 2030

Where this trial is recruiting

🇧🇪 Belgium

Primary endpoints

Change of IBS Symptom severity

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov